bay n 7133 has been researched along with clotrimazole in 2 studies
Studies (bay n 7133) | Trials (bay n 7133) | Recent Studies (post-2010) (bay n 7133) | Studies (clotrimazole) | Trials (clotrimazole) | Recent Studies (post-2010) (clotrimazole) |
---|---|---|---|---|---|
37 | 1 | 0 | 2,005 | 299 | 503 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cauwenbergh, G | 1 |
Abbott, AB; Odds, FC; Webster, CE | 1 |
2 other study(ies) available for bay n 7133 and clotrimazole
Article | Year |
---|---|
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |